Scarica l'app Stockscreener
180.10
0.38%
-0.69
Dopo l'orario di chiusura:
180.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$180.79
Aprire:
$181.45
Volume 24 ore:
3.13M
Relative Volume:
0.70
Capitalizzazione di mercato:
$127.47B
Reddito:
$24.78B
Utile/perdita netta:
$3.68B
Rapporto P/E:
34.81
EPS:
5.1743
Flusso di cassa netto:
$5.29B
1 W Prestazione:
-2.28%
1M Prestazione:
+8.32%
6M Prestazione:
-20.43%
1 anno Prestazione:
-12.19%
Intervallo 1D:
$179.50
$182.64
Intervallo di 1 settimana:
$177.93
$189.21
Portata 52W:
$160.93
$242.80
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
180.10 | 127.47B | 24.78B | 3.68B | 5.29B | 5.1743 |
TMO
Thermo Fisher Scientific Inc
|
469.34 | 174.42B | 45.20B | 6.87B | 6.75B | 18.19 |
IDXX
Idexx Laboratories Inc
|
560.88 | 44.24B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
129.84 | 36.67B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
355.53 | 34.91B | 3.77B | 449.25M | 240.68M | 7.8556 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
Danaher Corp. Stock (US2358511028): shares in focus after quiet trading week - AD HOC NEWS
Is Danaher stock underperforming the S&P 500? - MSN
Danaher Masimo Deal Strengthens S&P 500 Healthcare Growth Story - Kalkine Media
Masimo (MASI) director equity cashed out at $180 per share in Danaher merger - Stock Titan
Masimo (MASI) EVP equity cashed out and converted in Danaher merger - Stock Titan
Masimo (MASI) CCO reports merger-driven cancellation and conversion of equity awards - Stock Titan
Masimo (MASI) CHRO equity canceled, cashed out and rolled into Danaher - Stock Titan
Masimo (MASI) GC reports RSU disposals as Danaher merger converts awards - Stock Titan
Masimo (MASI) CMO disposes RSUs, options as Danaher merger closes - Stock Titan
Masimo (MASI) CFO exits company stock as Danaher cash merger closes - Stock Titan
Masimo (MASI) CEO awards canceled, paid $180 per share in Danaher deal - Stock Titan
3 Reasons to Avoid DHR and 1 Stock to Buy Instead - Yahoo Finance
Danaher boosts product portfolio with the acquisition of Masimo - MSN
Danaher Boosts Product Portfolio With the Acquisition of Masimo - TradingView
Implied Volatility Surging for Danaher Stock Options - Yahoo! Finance Canada
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
DHR Initiated Coverage On by Piper Sandler -- Price Target Annou - GuruFocus
1 Unstoppable Healthcare Cash Cow to Buy Hand Over Fist and Hold for 25 Years - Yahoo Finance
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
Strong Performance Continues at DHR's Biotechnology Unit: What's Next? - Yahoo Finance
Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)? - Yahoo Finance
Danaher Closes $9.9B Acquisition of Masimo - Medical Product Outsourcing
Piper Sandler initiates Danaher stock coverage with neutral rating By Investing.com - Investing.com Canada
Piper Sandler initiates Danaher stock coverage with neutral rating - Investing.com
Danaher closes $9.9B Masimo buyout - Yahoo Finance
Why Is Danaher Drawing Attention Among Bluestock Indices Trends? - Kalkine Media
Danaher Closes on Acquisition of Masimo - Orange County Business Journal
Danaher Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Danaher completes acquisition of Masimo, company delists from Nasdaq - Investing.com UK
Danaher completes acquisition of Masimo, company delists from Nasdaq By Investing.com - Investing.com Nigeria
Danaher (DHR) Completes Acquisition of Masimo, Expanding Diagnos - GuruFocus
Danaher Completes Acquisition of Masimo, Expanding Acute Care Diagnostics Platform - citybiz
Danaher completes $10B acquisition of Masimo - MassDevice
Masimo Pays Off and Terminates 2025 Credit Agreement as Danaher Merger Closes - TradingView
Danaher acquires Masimo (MASI) in all-cash $180-per-share takeover and delisting - Stock Titan
Danaher completes acquisition of Masimo Corporation - Investing.com
Danaher completes acquisition of Masimo Corporation By Investing.com - Investing.com Canada
Danaher buys Masimo, adding AI patient-monitoring tech in acute care - Stock Titan
Danaher Corporation $DHR Shares Sold by Motley Fool Wealth Management LLC - MarketBeat
Danaher Corporation $DHR Shares Acquired by Cerity Partners LLC - MarketBeat
Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Wolfe Research Downgrades Danaher Corporation (DHR) - Insider Monkey
Clearbridge Investments LLC Trims Stock Holdings in Danaher Corporation $DHR - MarketBeat
Danaher (DHR) Moves Towards Acquisition of Masimo (MASI) - GuruFocus
SIRI Stock Surges 5% After-Hours On S&P MidCap 400 Inclusion - TradingView
As Danaher nears Masimo deal, Sirius XM moves into S&P index - Stock Titan
Danaher Corp. stock (US2358511028): Diagnostics and life science group after recent earnings in focu - AD HOC NEWS
Phenomenex Introduces Luna Omega HILIC LC Columns to Increase Sensitivity and Consistency in Polar Compound Analysis - PR Newswire
Why Wall Street Sees Danaher (DHR) Benefiting From Improving Industry Conditions - Yahoo Finance
Top 5 Stocks That Members of Congress Own - Insider Monkey
Danaher Insiders Sold US$235m Of Shares Suggesting Hesitancy - Yahoo Finance
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.33%
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):